Franklin Resources’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Franklin Resources’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,039	Closed	-$212K	–	3107
2024 Q4	$212K	Buy	+22,039	New	+$115K	﹤0.01%	2631
2024 Q2	–	Sell	-21,811	Closed	-$69.6K	–	2993
2024 Q1	$69.6K	Sell	21,811 -17,133	-44%	-$57.1K	﹤0.01%	2744
2023 Q4	$131K	Sell	38,944 -56	-0.1%	-$144	﹤0.01%	2436
2023 Q3	$92.8K	Buy	+39,000	New	+$81.7K	﹤0.01%	2463

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Franklin Resources's PSTX Position: Q1 2025 in Review

Franklin Resources sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 22,039 shares — an estimated $212K sold.

Franklin Resources first reported a position in PSTX in Q3 2023 and held it in 4 quarters. The position peaked at $212K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Franklin Resources reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Franklin Resources sold 22,039 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $212K.
Franklin Resources first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Franklin Resources's Poseida Therapeutics, Inc. Common Stock position peaked at $212K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.